View record

Therapeutic role of inhibitors of Hyaluronan in schwannoma associated with Neurofibromatosis type 2
33/7/2019-TF/Rare/BMS

ICMR
Sept. 1, 2020

Aug. 31, 2023
Three Year

Neurofibromatosis type 2
None

None
To characterize and compare different molecular species of hyaluronan (HA) in the CSF of benign as well as malignant tumours of the CNS; To explore and compare the anti-proliferative role of HA inhibi

Neurofibromatosis Type 2, Schwannoma, Meningioma, Hyaluronic acid, CD44, Cerebrospinal fluid
None

36,25,398/-


Dr. Prasanth Ariyannur/None/Department of Molecular biology Amrita institute of medical sciences , Tamil Nadu

Dr. Ashok Pillai/None/Amrita Institute of medical sciences , Kochi

Sheela Nampoothiri/None/Dept. of Paediatric Genetics